Physician profile
Brooke Sands
NPI 1740970110
$4,103.50
in general payments reported to CMS, 2019-2025
13 companies · $663 in 2025
The $663 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,233 · 2024: $2,208 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,246 · Travel and Lodging: $1,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,246.49 |
| Travel and Lodging | $1,857.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,392.95 | 2023-2025 | Inspace, Procinch, Alphavent |
| Arthrex, INC. | $616.16 | 2023 | |
| Polaris Technology Solutions LLC | $320.31 | 2023 | |
| Bioventus LLC | $287.85 | 2024-2025 | Durolane, Xcell, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $147.54 | 2023-2025 | Monovisc, Dynacord, Speedtrap |
| Vericel Corporation | $83.56 | 2023-2024 | Maci |
| Vertex Pharmaceuticals Incorporated | $74.24 | 2025 | |
| Boston Scientific Corporation | $58.68 | 2024 | Wavewriter Alpha Prime 16 |
| Davol INC. | $35.40 | 2025 | Arista |
| Smith+Nephew, INC. | $30.48 | 2024 | Novostitch |
| Orthofix Medical, INC. | $25.90 | 2024 | Accelstim, Physio-Stim |
| Ferring Pharmaceuticals INC. | $16.45 | 2025 | Euflexxa |
| Painteq LLC | $13.98 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Sands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.